|
|||||
Transplant Statistics: Annual Report
Technical Notes and Analytic Methods
Donor and Recipient Tumor Data
The donor and recipient tumor tables show overall frequency counts for donors with a history of cancer, as well as recipient recurrence of pretransplant malignancies, de novo (non-recurrent) posttransplant solid malignancies, and posttransplant lymphoproliferative disorder. Frequency counts and percentages of the type of cancer also are shown for the above mentioned data for kidney, liver, and heart. The donor and recipient tumor tables are presented as follows:
Data on organs from donors with either a history of cancer or cancer seen at the time of procurement are obtained from the CDR form. Donor data are presented for organs transplanted between 1994 and 2000, as cancer history information was not collected prior to 1994.
Recipient tumor data are taken from the TCR, TRR, and TRF forms.
The OPTN began collecting data on Posttransplant lymphoproliferative disorder (PTLD) following thoracic organ transplants in 1994 and in 1996 following all other organ transplants. The data in this edition of the Annual Report includes all reports of PTLD since this time.
Although the OPTN has historically collected data on other posttransplant malignancies, until recently these data did not specify whether the tumor was recurrent or de novo (non-recurrent), and there were few details regarding the specific cancer site. Detailed tumor data collection began in 1999. Thus, this edition of the Annual Report presents data obtained since 1999.
Organ-specific data on the type of cancer are shown for kidney, liver, and heart. Due to the small number of tumors for other transplanted organs, there are no other organ-specific tables presented here.
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.